Initial Treatment for Hypertensive Crisis
For hypertensive emergencies (severe BP elevation >180/120 mmHg with evidence of acute end-organ damage), immediate intravenous therapy with labetalol is recommended as the first-line treatment for most clinical presentations. 1
Classification of Hypertensive Crisis
- Hypertensive crisis is defined as severe blood pressure elevation (>180/120 mmHg) and is categorized into two distinct types 2, 1:
- Hypertensive emergency: Severe BP elevation with evidence of new or worsening target organ damage
- Hypertensive urgency: Severe BP elevation without acute end-organ damage
Treatment Approach Based on Classification
Hypertensive Emergencies (with acute end-organ damage)
Require immediate admission to an Intensive Care Unit for continuous BP monitoring and parenteral administration of appropriate agents 2
Treatment should be initiated with titratable intravenous antihypertensive medications 1, 3
First-line medications include:
- Labetalol IV: Recommended by the European Society of Cardiology as first-line for most hypertensive emergencies due to its combined alpha and beta-blocking properties 1, 4
- Nicardipine: Effective calcium channel blocker with fewer adverse effects than nitroprusside 2, 3
- Clevidipine: Newer agent with advantages in management of hypertensive emergencies 3
- Fenoldopam: Particularly useful in patients with renal impairment 2, 5
Specific situation-based recommendations:
Hypertensive Urgencies (without acute end-organ damage)
- Can usually be treated with oral antihypertensive agents 2, 6
- Patients can typically be discharged after a brief period of observation 2
- Avoid short-acting nifedipine as it is no longer considered acceptable in the initial treatment 2
Treatment Goals and Monitoring
- For hypertensive emergencies, reduce mean arterial pressure by 20-25% within the first hour 1
- Further reduce BP to 160/100 mmHg within the next 2-6 hours 1
- Cautiously normalize blood pressure over the following 24-48 hours 1
- Precipitate renal, cerebral, or coronary ischemia should be avoided during BP reduction 2
- Intra-arterial BP monitoring is recommended for patients receiving nitroprusside 1
Medications to Avoid
- Sodium nitroprusside: Despite being traditionally used, it is extremely toxic and should be avoided when possible 3, 5
- Short-acting nifedipine: No longer considered acceptable in initial treatment 2
- Hydralazine: Associated with significant toxicities and unpredictable antihypertensive effects 3, 7
Special Considerations
- In patients with pheochromocytoma, labetalol may worsen hypertension in some cases; phentolamine, nitroprusside, or urapidil are preferred 2, 1
- Beta-blockers, including labetalol, are relatively contraindicated in patients with reactive airway disease or COPD 1
- For ischemic stroke patients, there is no clear evidence from clinical trials to support immediate antihypertensive treatment 2
- In patients with aortic dissection, SBP should be lowered to 100 mmHg if tolerated 2
Follow-up Care
- Concomitant longer-acting antihypertensive medication should be administered to minimize the duration of treatment with IV agents 8
- Frequent follow-up (at least monthly) in a specialized setting is recommended until target blood pressure is reached 1
- Patients admitted for hypertensive emergency remain at increased risk of cardiovascular and renal disease and require close monitoring 2